Eli Lilly & Co. (LLY)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 5 |
Ownership rank: | 93 |
% of all portfolios: | 0.088% |
Hold Price * : | $777.96 |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
82 |
$608,250,580 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
≡ |
Chase Coleman - Tiger Global Management |
3.78 |
|
890,000 |
692,384,000 |
≡ |
Mairs & Power Growth Fund |
1.78 |
|
124,539 |
96,886,000 |
≡ |
Polen Capital Management |
1.05 |
Reduce 1.68% |
584,806 |
454,956,000 |
≡ |
Viking Global Investors |
0.39 |
Reduce 2.97% |
134,608 |
104,720,000 |
≡ |
David Katz - Matrix Asset Advisors |
0.03 |
Buy |
297 |
231,000 |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
16 Aug 2022 |
TAI JACKSON P |
Director |
12 Aug 2022 |
656 |
304.19 |
199,549 |
07 Mar 2022 |
RUNGE MARSCHALL S |
Director |
01 Mar 2022 |
202 |
246.78 |
49,850 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock